IBDEI0U1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13514,1,3,0)
 ;;=3^Personal Hx of Non-Suicidal Self-Harm
 ;;^UTILITY(U,$J,358.3,13514,1,4,0)
 ;;=4^Z91.52
 ;;^UTILITY(U,$J,358.3,13514,2)
 ;;=^5161318
 ;;^UTILITY(U,$J,358.3,13515,0)
 ;;=Z91.51^^51^638^2
 ;;^UTILITY(U,$J,358.3,13515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13515,1,3,0)
 ;;=3^Personal Hx of Suicidal Behavior     
 ;;^UTILITY(U,$J,358.3,13515,1,4,0)
 ;;=4^Z91.51
 ;;^UTILITY(U,$J,358.3,13515,2)
 ;;=^5161317
 ;;^UTILITY(U,$J,358.3,13516,0)
 ;;=Z82.1^^51^639^1
 ;;^UTILITY(U,$J,358.3,13516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13516,1,3,0)
 ;;=3^Family Hx Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,13516,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,13516,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,13517,0)
 ;;=Z83.518^^51^639^3
 ;;^UTILITY(U,$J,358.3,13517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13517,1,3,0)
 ;;=3^Family Hx Other Specified Eye Disorder
 ;;^UTILITY(U,$J,358.3,13517,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,13517,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,13518,0)
 ;;=Z83.511^^51^639^2
 ;;^UTILITY(U,$J,358.3,13518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13518,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,13518,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,13518,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,13519,0)
 ;;=97533^^52^640^18^^^^1
 ;;^UTILITY(U,$J,358.3,13519,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13519,1,2,0)
 ;;=2^97533
 ;;^UTILITY(U,$J,358.3,13519,1,3,0)
 ;;=3^Sensory Integration Techniques,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13520,0)
 ;;=97535^^52^640^17^^^^1
 ;;^UTILITY(U,$J,358.3,13520,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13520,1,2,0)
 ;;=2^97535
 ;;^UTILITY(U,$J,358.3,13520,1,3,0)
 ;;=3^Self-Care Mgmt/ADL,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13521,0)
 ;;=97110^^52^640^19^^^^1
 ;;^UTILITY(U,$J,358.3,13521,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13521,1,2,0)
 ;;=2^97110
 ;;^UTILITY(U,$J,358.3,13521,1,3,0)
 ;;=3^Therapy/Exercise,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13522,0)
 ;;=97116^^52^640^4^^^^1
 ;;^UTILITY(U,$J,358.3,13522,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13522,1,2,0)
 ;;=2^97116
 ;;^UTILITY(U,$J,358.3,13522,1,3,0)
 ;;=3^Basic Mobility/Gait Training,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13523,0)
 ;;=97755^^52^640^3^^^^1
 ;;^UTILITY(U,$J,358.3,13523,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13523,1,2,0)
 ;;=2^97755
 ;;^UTILITY(U,$J,358.3,13523,1,3,0)
 ;;=3^Assistive Technology Assessment,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13524,0)
 ;;=T1016^^52^640^5^^^^1
 ;;^UTILITY(U,$J,358.3,13524,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13524,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,13524,1,3,0)
 ;;=3^Case Management,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13525,0)
 ;;=G9012^^52^640^6^^^^1
 ;;^UTILITY(U,$J,358.3,13525,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13525,1,2,0)
 ;;=2^G9012
 ;;^UTILITY(U,$J,358.3,13525,1,3,0)
 ;;=3^Case Mangement,NEC,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13526,0)
 ;;=97750^^52^640^16^^^^1
 ;;^UTILITY(U,$J,358.3,13526,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13526,1,2,0)
 ;;=2^97750
 ;;^UTILITY(U,$J,358.3,13526,1,3,0)
 ;;=3^Physical Performance Test,Ea 15 min
 ;;^UTILITY(U,$J,358.3,13527,0)
 ;;=98960^^52^640^8^^^^1
 ;;^UTILITY(U,$J,358.3,13527,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13527,1,2,0)
 ;;=2^98960
 ;;^UTILITY(U,$J,358.3,13527,1,3,0)
 ;;=3^Ed/Training,Self-Mgmnt,1 Pt,Ea 15 min
